Connected profileLeuprolide
Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Leuprolide Acetate clinical trials
10 selected ClinicalTrials.gov records carrying the official matched intervention Leuprolide Acetate (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
Registry records
10 selected records.
Connected peptides
1 profiles.
Source boundary
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 46 selected PubMed records and 24 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
Record added
ClinicalTrials.gov record NCT00170157
PeptideScanner retained ClinicalTrials.gov record NCT00170157 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-05-15, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- May 15, 2017
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT00429494
PeptideScanner retained ClinicalTrials.gov record NCT00429494 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-07-09, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- July 9, 2013
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT00589472
PeptideScanner retained ClinicalTrials.gov record NCT00589472 at 2026-07-30T21:22:00.251Z. Its registry update date was 2017-10-06, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- October 6, 2017
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Leuprolide · 2026-07-28
ClinicalTrials.gov record NCT04484818
Active, not recruiting at the retained observation.
Open attributed record →Leuprolide · 2026-07-28
ClinicalTrials.gov record NCT06169124
Active, not recruiting at the retained observation.
Open attributed record →Leuprolide · 2026-07-09
ClinicalTrials.gov record NCT02319837
Active, not recruiting at the retained observation.
Open attributed record →Leuprolide · 2018-02-26
ClinicalTrials.gov record NCT01120236
Completed at the retained observation.
Open attributed record →Leuprolide · 2017-11-20
ClinicalTrials.gov record NCT01762943
Completed at the retained observation.
Open attributed record →Leuprolide · 2017-10-06
ClinicalTrials.gov record NCT00589472
Completed at the retained observation.
Open attributed record →Leuprolide · 2017-05-15
ClinicalTrials.gov record NCT00170157
Completed at the retained observation.
Open attributed record →Leuprolide · 2016-09-19
ClinicalTrials.gov record NCT01076335
Completed at the retained observation.
Open attributed record →Leuprolide · 2014-06-04
ClinicalTrials.gov record NCT01669291
Completed at the retained observation.
Open attributed record →Leuprolide · 2013-07-09
ClinicalTrials.gov record NCT00429494
Completed at the retained observation.
Open attributed record →